ARCHIVES

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

This article is from The Cancer Letter archive.

Vol. 34 No. 46 | December 19, 2008

Download PDF Visit The Full Archive

Related Articles

PRI Asks NIH To Cancel Recompetition Of Frederick Center Operations Contract

February 17, 1995

FDA Approves New Drug for Advanced Kidney Cancer

May 25, 2007

FDA, NCI Near Agreement On Handling INDs

January 28, 1977

National Dialogue On Cancer, The Cancer Act, And Activism.

February 4, 2000

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

November 18, 2011

Funding Opportunities

October 18, 2002